Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231

Biomedicine and Pharmacotherapy

Volumn 57, Issue 8, 2003, Pages 333-340

  Bando, Hiroko ^a,b   Toi, Masakazu ^a   Kitada, Kunio ^c   Koike, Morio ^b  

^a Tokyo Metropol Cancer/Infect D   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

Breast cancer; Hypoxia; Microarray

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ALPHA 1 ANTITRYPSIN; AUTOANTIGEN; CASEIN KINASE II; CHOLESTEROL ESTER TRANSFER PROTEIN; HEME OXYGENASE; HOMEODOMAIN PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTEGRIN; LACTATE DEHYDROGENASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MEGALIN; METALLOPROTEINASE INHIBITOR; MINERALOCORTICOID RECEPTOR; NERVE CELL ADHESION MOLECULE; NITRIC OXIDE SYNTHASE; NUCLEAR FACTOR; OXYGENASE; PHOSPHOGLYCERATE KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASOME; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN TYROSINE KINASE; SERINE PROTEINASE; SUPEROXIDE DISMUTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL HYPOXIA; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE IDENTIFICATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

EID: 0141927332     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(03)00098-2     Document Type: Article

References (42)

1. Amirkhosravi A., Meyer T., Chang J.Y., Amaya M., Siddiqui F., Desai H., et al. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost. 87:2002;930-936.
2. Bates S., Rowan S., Vousden K.H. Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene. 13:1996;1103-1109.
3. Bruik R.K. Expression of the gene encoding the proapoptotic BNIP3 protein is induced by hypoxia. Proc Natl Acad Sci USA. 97:2000;9082-9087.
4. Chia S.K., Wykoff C.C., Watson P.H., Han C., Leek R.D., Pastorek J., et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol. 19:2001;3660-3668.
5. Dachs G.U., Dougherty G.J., Stratford I.J., Chaplin D.J. Targeting gene expression to hypoxic tumor cells. Nat M. 3:1997;515-520.
6. Dong Z., Venkatachalam M.A., Wang J., Patel Y., Saikumar P., Semenza G.L., et al. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J Biol Chem. 276:2001;18702-18709.
7. Firth J.D., Ebert B.L., Pugh C.W., Ratcliffe P.J. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci USA. 91:1994;6496-6500.
8. Graeber T.G., Peterson J.F., Tsai M., Monica K., Fornace A.J. Jr, Giaccia A.J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol. 14:1994;6264-6277.
9. Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C.J., Lowe S.W., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:1996;88-91.
10. Gruvberger S., Ringner M., Chen Y., Panavally S., Saal L.H., Borg A., et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61:2001;5979-5984.
11. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., Englert C., et al. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell. 1999;97575-97586.
12. Harris A.L. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer. 2:2002;38-47.
13. Helczynska K., Kronblad A., Jogi A., Nilsson E., Beckman S., Landberg G., et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 63:2003;1441-1444.
14. Horne M.C., Goolsby G.L., Donaldson K.L., Tran D., Neubauer M., Wahl A.F. Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem. 272:1997;12650-12661.
15. Ishii M., Hashimoto S., Tsutsumi S., Wada Y., Matsushima K., Kodama T., et al. Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics. 68:2000;136-143.
16. Ivanova A.V., Ivanov S.V., Danilkovitch-Miagkova A., Lerman M.I. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway. J Biol Chem. 276:2001;15306-15315.
17. Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.E., Lee S.W., et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat M. 7:2001;437-443.
18. Kress S., Stein A., Maurer P., Weber B., Reichert J., Buchmann A., et al. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol. 124:1998;315-320.
19. Koukourakis M.I. Tumour angiogenesis and response to radiotherapy. Anticancer Res. 21:2001;4285-4300.
20. Lee S.B., Huang K., Palmer R., Truong V.B., Herzlinger D., Kolquist K.A., et al. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell. 98:1999;663-673.
21. Lipshutz R.J., Fodor S.P., Gingeras T.R., Lockhart D.J. High density synthetic oligonucleotide arrays. Nat Genet. 21:1999;20-24.
22. Littlewood T.J., Bajetta E., Nortier J.W., Vercammen E., Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 19:2001;2865-2874.
23. Littlewood T.J. The impact of hemoglobin levels on treatment outcomes in patients with cancer. Semin Oncol. 28:2001;49-53.
24. Mathupala S.P., Heese C., Pedersen P.L. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem. 272:1997;22776-22780.
25. Mathupala S.P., Rempel A., Pedersen P.L. Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem. 276:2001;43407-43412.
26. Miyoshi Y., Iwao K., Egawa C., Noguchi S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer. 92:2001;370-373.
27. Nissi R., Autio-Harmainen H., Marttila P., Sormunen R., Kivirikko K.I. Prolyl 4-hydroxylase isoenzymes I and II have different expression patterns in several human tissues. J Histochem Cytochem. 49:2001;1143-1153.
28. Novak J.P., Sladek R., Hudson T.J. Characterization of variability in large-scale gene expression data: implications for study design. Genomics. 79:2002;104-113.
29. Park H., Adams M.A., Lachat P., Bosman F., Pang S.C., Graham C.H. Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun. 276:2000;321-328.
30. Piper M.D., Daran-Lapujade P., Bro C., Regenberg B., Knudsen S., Nielsen J., et al. Reproducibility of oligonucleotide microarray transcriptome analyses. An interlaboratory comparison using chemostat cultures of Saccharomyces cerevisiae. J Biol Chem. 277:2002;37001-37008.
31. Schindl M., Schoppmann S.F., Samonigg H., Hausmaninger H., Kwasny W., Gnant M., et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 8:2002;1831-1837.
32. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol M. 7:2001;345-350.
33. Semenza G.L., Roth P.H., Fang H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 269:1994;23757-23763.
34. Shoshani T., Faerman A., Mett I., Zelin E., Tenne T., Gorodin S., et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol. 22:2002;2283-2293.
35. Sowter H.M., Ratcliffe P.J., Watson P., Greenberg A.H., Harris A.L. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61:2001;6669-6673.
36. Sun H., Lu B., Li R.Q., Flavell R.A., Taneja R. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat Immunol. 2:2001;1040-1047.
37. Takahashi Y., Takahashi S., Shiga Y., Yoshimi T., Miura T. Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J Biol Chem. 275:2000;14139-14146.
38. Vande Velde C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol. 20:2000;5454-5468.
39. Wilson J.W., Deed R.W., Inoue T., Balzi M., Becciolini A., Faraoni P., et al. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 61:2001;8803-8810.
40. Wykoff C.C., Pugh C.W., Maxwell P.H., Harris A.L., Ratcliffe P.J. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumor suppressor by mRNA differential expression profiling. Oncogene. 19:2000;6297-6305.
41. Yan S.F., Lu J., Zou Y.S., Soh-Won J., Cohen D.M., Buttrick P.M., et al. Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem. 274:1999;15030-15040.
42. Yuen T., Wurmbach E., Pfeffer R.L., Ebersole B.J., Sealfon S.C. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 30:2002;e48.